DB:0II

Stock Analysis Report

Executive Summary

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia.

Snowflake

Fundamentals

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has Invuity's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

1.0%

0II

-1.8%

DE Medical Equipment

2.4%

DE Market


1 Year Return

-21.9%

0II

16.5%

DE Medical Equipment

2.3%

DE Market


Shareholder returns

0IIIndustryMarket
7 Day1.0%-1.8%2.4%
30 Day2.8%1.0%-0.2%
90 Day84.5%-0.7%0.6%
1 Year-21.9%-21.9%18.4%16.5%5.5%2.3%
3 Yearn/a104.9%99.7%18.9%8.6%
5 Yearn/a295.5%275.7%44.8%25.1%

Price Volatility Vs. Market

How volatile is Invuity's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Invuity undervalued compared to its fair value and its price relative to the market?

76.29x

Price to Book (PB) ratio


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is Invuity forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

34.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

High Growth Earnings: 0II is forecast to remain unprofitable over the next 3 years.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Invuity performed over the past 5 years?

-15.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is Invuity's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Information is not available.

Information is not available.


Next Steps

Dividend

What is Invuity's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.9%industryaverage1.4%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Information is not available.

Information is not available.

Stable Dividend: Insufficient data to determine if 0II's dividends per share have been stable in the past.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Invuity's salary, the management and board of directors tenure and is there insider trading?

1.0yrs

Average management tenure


CEO

Scott Flora (62yo)

0.6yrs

Tenure

US$165,079

Compensation

Mr. Scott D. Flora serves as President of SFlora Consulting LLC since 2016. Mr. Flora has been Interim President and Chief Executive Officer at Invuity, Inc. since March 01, 2018. He served as the Chief Ex ...


Management Age and Tenure

1.0yrs

Average Tenure

54yo

Average Age

Information is not available.


Board Age and Tenure

3.1yrs

Average Tenure

60yo

Average Age

Information is not available.


Insider Trading

Information is not available.


Ownership Breakdown


Management Team

  • Doug Heigel (57yo)

    Senior Vice President of Operations

    • Tenure: 4.1yrs
    • Compensation: US$536.13k
  • Scott Flora (62yo)

    Interim President

    • Tenure: 0.6yrs
    • Compensation: US$165.08k
  • Jim MacKaness (54yo)

    Chief Financial Officer

    • Tenure: 3.2yrs
    • Compensation: US$690.59k
  • Steven Annen (54yo)

    Vice President of Product Management & Strategy

    • Tenure: 2.5yrs
  • Marcia Fish (54yo)

    Chief Human Resources Officer

    • Tenure: 1yrs
  • Sham Shiblaq

    Vice President of Commercial Operations

    • Tenure: 0.4yrs
  • Lauren Budesheim

    Senior Director of Human Resources

    • Tenure: 0.3yrs

Board Members

  • Randy Lipps (61yo)

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: US$196.50k
  • Bill Burke (59yo)

    Independent Director

    • Tenure: 3.4yrs
    • Compensation: US$207.50k
  • Greg Lucier (54yo)

    Independent Chairman

    • Tenure: 2.8yrs
    • Compensation: US$223.69k
  • Daniel Wolterman (61yo)

    Director

    • Tenure: 1.1yrs
    • Compensation: US$142.63k
  • Scott Flora (62yo)

    Interim President

    • Tenure: 0.6yrs
    • Compensation: US$165.08k
  • Eric Roberts (54yo)

    Independent Director

    • Tenure: 6.3yrs
    • Compensation: US$190.57k

Company Information

Invuity, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Invuity, Inc.
  • Ticker: 0II
  • Exchange: DB
  • Founded: 2004
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$177.990m
  • Listing Market Cap: US$155.225m
  • Shares outstanding: 24.09m
  • Website: https://www.invuity.com

Number of Employees


Location

  • Invuity, Inc.
  • 444 De Haro Street
  • San Francisco
  • California
  • 94107
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IVTYNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJun 2015
0IIDB (Deutsche Boerse AG)YesCommon StockDEEURJun 2015

Biography

Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and r ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2018/10/23 18:43
End of Day Share Price2018/10/22 00:00
Earnings2018/06/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.